Veradermics, Incorporated (MANE) is in Healthcare, Biotechnology, based in United States, listed on NYSE. Market cap 5.29B USD. 52-week range 32.00 to 136.72 USD. Data as of 2026-10-09.
Veradermics, Incorporated, a clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting adults and children. The company's products include VDPHL01, an oral, non-hormonal treatment for men and women with PHL for chronic hair loss therapy. Additionally, it engages in the development of VDMN, a dissolvable microarray patch technology for immunotherapy of common warts; ...